Evidence map›Paper›PMID 28611731›Full record

ArticleFrontiers in microbiology2017

The Genomic Architecture of Novel

James L Crainey, Jacob Hurst, Poppy H L Lamberton, Robert A Cheke, Claire E Griffin, Michael D Wilson, Cláudia P Mendes de Araújo, María-Gloria Basáñez, Rory J Post

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

James L CraineyLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Fundação Oswaldo Cruz, Instituto Leônidas e Maria DeaneManaus, Brazil.
Jacob HurstOxford Martin School, Institute for Emerging Infections, University of OxfordOxford, UK.
Poppy H L LambertonInstitute of Biodiversity, Animal Health and Comparative Medicine, Wellcome Centre for Molecular Parasitology, University of GlasgowGlasgow, UK.
Robert A ChekeNatural Resources Institute, University of Greenwich at MedwayChatham, UK.
Claire E GriffinCore Research Laboratories Department, Molecular Biology Laboratories Division, Natural History MuseumLondon, UK.
Michael D WilsonNoguchi Memorial Institute for Medical Research, University of GhanaAccra, Ghana.
Cláudia P Mendes de AraújoLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, Fundação Oswaldo Cruz, Instituto Leônidas e Maria DeaneManaus, Brazil.
María-Gloria BasáñezDepartment of Infectious Disease Epidemiology, Faculty of Medicine (St Mary's campus), London Centre for Neglected Tropical Disease Research, School of Public Health, Imperial College LondonLondon, UK.
Rory J PostSchool of Natural Sciences and Psychology, Liverpool John Moores UniversityLiverpool, UK.
Fundação Oswaldo Cruz · BRImperial College London · GBLiverpool John Moores University · GBLondon Centre for Neglected Tropical Disease Research · GBNatural History Museum · GBUniversity of Ghana · GHUniversity of Glasgow · GBUniversity of Oxford · GB

Funding

Medical Research Council 77615Wellcome Trust
6 · The paper itself

Abstract

Research interest in

Indexed as

onchocerciasisserine recombinaseSimulium squamosum ESpvB protein homologWolbachiaWolbachia phages

Identifiers

PMID28611731
PMCPMC5447182
OpenAlexW2614822252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.